Lactocore Overview
- Status
- Private
- Latest Deal Type
- Accelerator/Inc
- Investors
- 1
Lactocore General Information
Description
Developer of novel peptide-based therapies intended to address unmet medical needs of psychiatric conditions within the spectrum of depressive and anxiety disorders. The company's therapy helps to identify an unknown family of peptides with biological activity in anxiety and depression, by means of proprietary processing of whey and casein from bovine's milk, enabling baby food manufacturers to reduces the risk of the motor mental retardation through their food product.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Media and Information Services (B2B)
Primary Office
- 46701 Commerce Center Drive
- Plymouth, MI 48170
- United States
Lactocore Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 01-Apr-2012 | Completed | Pre-Clinical Trials |
Lactocore Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Askar Kuchumov Ph.D | Chief Executive Officer | ||
| Igor Doronin | Co-Founder & Director of PD | ||
| Anton Malyshev | Co-Founder & CSO | ||
| Gennady Babkin | Co-Founder |
Lactocore Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| MSU Business Incubator | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |